Huitianfu Fund Management Co., Ltd.

Huitianfu Fund Management Co., Ltd. (also known as China Universal Asset Management) is a comprehensive asset management company in China, founded in February 2005. Headquartered in Shanghai, the firm manages a wide range of products including public funds, private funds, and provides services for various institutional clients. It was one of the first Chinese asset managers to receive a Qualified Domestic Institutional Investor (QDII) license and has subsidiaries in Hong Kong, the United States, and Singapore. The company is known for its equity investment expertise and offers products across various asset classes like stocks, bonds, and money market instruments. The firm was an investor in the Series C financing round for Duoning Biotechnology in November 2021.